维普期刊资源整合服务平台（V6.5）

106篇 您的检索式：作者名="S Brienza"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences显示文摘	Boisdron-celle M Craipeau C Brienza S	2002	Cancer Chemother Pharmacol2002，49，3：	1
2	Phase IT study of oxaliplatin in poor-prognosis non-small cell lung cance显示文摘	Monnel I Brienza S Hugret F	1998	Eur J Cancer1998，34，7：	1
3	Phase Ⅱstudy of oxaliplatin in poor-prognosis non-small cell lung cancer 显示文摘	Monnel Ⅰ Brienza S Hugret F	1998	Europ J of Cancer1998，34，7：	1
4	Phase-I trial of 5-day continous venous infusion of oxaliplatin at circadian rhythmmodulated rate comared with constant rate显示文摘	Caussanel J P Levi F Brienza S	1990	J Natl Cancer Inst1990，82，12：	1
5	Pharmacokinetics and safety profile on oxaliplatin显示文摘	EXTRA J M MARTY M BRIENZA S	1998	Semin Oncol1998，25，5：	1
6	A chronopharmacologic phase Ⅱclinical trial with 5-fluorouracil, folinic acid and oxaliplatin using an ambulatory multichannel programmable pump:High antitumor effeetiveness against metastatic colorectal cancer显示文摘	Levi F Misset J L Brienza S	1992	Cancer1992，69，4：	1
7	phamacokinetics and safety profile on oxaliplatin显示文摘	Extra JM Marty M Brienza S	1998	Semin Oncol1998，25，5：	1
8	Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin' s lymphoma patients显示文摘	Germann N Brienza S Rotarski M	1999	Ann Oncol1999，10，3：	1
9	Phase Ⅱ study of oxaliplatin in poor - prognosis non - small cell lung cancer(NSCLC) 显示文摘	Monnet I Brienza S Hugret F	1998	Eur J Cancer1998，34，7：	1
10	Pharmaeokineties and safety Profile of oxaliPlatin显示文摘	Extra JM Marty M Brienza S	1998	SeminOneol1998，25，：	1
11	Phase Ⅱ study of oxaliplatin in poor-prognosis non-small cell lung cancer显示文摘	Brienza S Hugret F	1998	Europ J Cancer1998，34，7：	1
12	Pharmacokinetics and safety profile on Oxaliplatin 显示文摘	Extra JM Marty M Brienza S	1998	Semin Oncol1998，25，5：	1
13	Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer(NSCLC)显示文摘	Monnet I Brienza S Hugret F		0，，07：	1
14	Pharmacokinetics and safety profile of oxaliplatin显示文摘	Extra JM Marty M Brienza S		0，，2：	1
15	A multicenter evaluation of intensified,ambulatory,chronomodulated chemotherapy with oxaliplatin,5-fluorouracil,and leucovorin as initial treatment of patients with metastatic colorectal carcinoma显示文摘	Levi F Zidani R Brienza S	1999	Cancer1999，85，12：	1
16	Influence of oxaliplatin on 5 - fluorouracil plasma clearance and clinical consequences 显示文摘	Boisdron - Celle M Craipeau C Brienza S	2002	Cancer Chemother Pharmacol2002，49，3：	1
17	A chronopharmacologic phase Ⅱ chinical trial with 5-fluorouracil,folinic acid,and oxalipatin using ambulatory multichannel programmable pump:High antitumor effectiveness against metastatic colorectal eancer显示文摘	Misset JL Brienza S	1992	Cancer1992，69，7：	1
18	Phase Ⅱ study ofoxaliplatin inpoor-prognosis non-small cell lung cancer显示文摘	Monnet I Brienza S Hugret F	1998	Eur J Cancer1998，34，7：	1
19	Pharmacokinetics and safety profile of oxaliplatin 显示文摘	Extra JM Marty M Brienza S	1998	Semin Oncol1998，25，1：	1
20	Pharmacokinetics and safety profile on oxaliplatin显示文摘	Extra JM Marty M Brienza S	1998	Sem in Oncol1998，25，25：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示